A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adju

['lizbeth]

This is a phase III clinical trial which is accruing worldwide. Many sites say active, not recruiting - I expect that enrollment at that location is full.

If you have finished surgeries but not started chemotherapy please check and see if the trial is recruiting in your area.

This is a great opportunity as Perjeta was just approved for pre-surgery use in some early stage cancer. It has demonstated effectiveness over the standard treatment of a taxane and Herceptin.